CasLoc logo
All Cases PTAB Litigations UPC Oppositions

AstraZeneca Pharmaceuticals LP v. Teva Pharmaceuticals USA

1:08-cv-00426

Overview

Case Number 1:08-cv-00426
Filing Date 2008-07-10
Status Terminated
Termination Date 2010-07-13
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Defendant

Parties

Defendant

Teva Pharmaceuticals USA Operating Company

Represented By

6 Attorneys Listed

John M. Seaman

Abrams & Bayliss LLP

Tel: +1 (302) 778-1000
Fax: +1 (302) 573-3501

20 Montchanin Road, Suite 200, Wilmington, DE 19807

Joseph H. Huston , Jr.

Stevens & Lee

Tel: +1 (302) 425-3310
Fax: +1 (610) 371-7972

919 North Market St., Suite 1300, Wilmington, DE 19801

Plaintiff

AstraZeneca Pharmaceuticals LP NPE (Individual / Inventor)

Represented By

9 Attorneys Listed

Mary W. Bourke

Womble Carlyle Sandridge & Rice, LLP

Tel: +1 (302) 252-4320

222 Delaware Ave., Suite 1501, Wilmington, DE 19801

AstraZeneca UK Limited NPE (University / Research)

Represented By

1 Attorneys Listed

Mary W. Bourke

Womble Carlyle Sandridge & Rice, LLP

Tel: +1 (302) 252-4320

222 Delaware Ave., Suite 1501, Wilmington, DE 19801

IPR Pharmaceuticals Inc. Operating Company

Represented By

1 Attorneys Listed

Mary W. Bourke

Womble Carlyle Sandridge & Rice, LLP

Tel: +1 (302) 252-4320

222 Delaware Ave., Suite 1501, Wilmington, DE 19801

Shionogi Seiyaku Kabushiki Kaisha Operating Company

Represented By

1 Attorneys Listed

Mary W. Bourke

Womble Carlyle Sandridge & Rice, LLP

Tel: +1 (302) 252-4320

222 Delaware Ave., Suite 1501, Wilmington, DE 19801

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
USRE37314
Pyrimidine derivatives
Filed: 1998-08-27
Issued: 2001-08-07
Expired (Term Ended)
Expires: 2016-01-08

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

12

Dispositive

1

Granted

1

Denied

0

Pending / Review

11

Motions by Category

Motion to Dismiss (FRCP 12(b)(6)) 1 Claim Construction / Markman Filing 8 Procedural / Extension Motion 3

Key Dispositive Motions & Rulings

Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
REPORT AND RECOMMENDATION REGARDING MOTIONS TO DISMISS -- recommended as follows:(1) In Civ. No. 07-806, Sun Pharmaceutical Industries Ltd.s Motion to Dismiss f...
Entry #29 • 2008-11-24 Document →
Procedural / Extension Motion Granted
ORDER granting (111) Motion to Amend/Correct in case 1:07-cv-00806-JJF-LPS; granting (103) Motion to Amend/Correct in case 1:07-cv-00805-JJF-LPS; granting (117)...
Entry #99 • 2009-04-03 Document →
Procedural / Extension Motion Pending / Under Review
MOTION to Amend/Correct 10 Answer to Complaint Unopposed Motion of Defendants Mylan Pharmaceuticals Inc., Sun Pharmaceutical Industries, Inc., Apotex Inc. and A...
Entry #91 • 2009-04-01 Document →
Procedural / Extension Motion Pending / Under Review
SEALED EXHIBIT re 91 MOTION to Amend/Correct 10 Answer to Complaint Unopposed Motion of Defendants Mylan Pharmaceuticals Inc., Sun Pharmaceutical Industries, In...
Entry #92 • 2009-04-01 Document →
Claim Construction / Markman Filing Pending / Under Review
Letter to Mr. Ron Golden from Mary W. Bourke regarding Request For Permission to bring Equipment into Courtroom for Markman Hearing. (Bourke, Mary) (Entered: 03...
Entry #71 • 2009-03-09 Document →
Claim Construction / Markman Filing Pending / Under Review
PROPOSED ORDER Permission to bring equipment into the courtroom for Markman Hearing by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, IPR Pharmaceutica...
Entry #72 • 2009-03-09 Document →

Docket Entries

(120 total)
Pleading / Complaint

COMPLAINT filed against Teva Pharmaceuticals USA - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0310000000000468467.) - filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, IPR Pharmaceuticals Inc., Shionogi Seiyaku Kabushiki Kaisha. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(ead) (Entered: 07/11/2008)

Entry #1 • 2008-07-10
1

Notice of Availability of a U.S. Magistrate Judge to Exercise Jurisdiction (ead) (Entered: 07/11/2008)

Entry #2 • 2008-07-10
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE37,314 E; (ead) (Entered: 07/11/2008)

Entry #3 • 2008-07-11
1
Pleading / Complaint

Return of Service Executed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, IPR Pharmaceuticals Inc., Shionogi Seiyaku Kabushiki Kaisha. Teva Pharmaceuticals USA served on 7/11/2008, answer due 7/31/2008. (Bourke, Mary) (Entered: 07/11/2008)

Entry #4 • 2008-07-11
1

Disclosure Statement pursuant to Rule 7.1 filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, IPR Pharmaceuticals Inc., Shionogi Seiyaku Kabushiki Kaisha. (Bourke, Mary) (Entered: 07/25/2008)

Entry #5 • 2008-07-25
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc